Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01632709 · ClinicalTrials.gov registry record · Phase 4
Pathophysiology of Post Amputation Pain
A Phase 4 study, sponsored by Shirley Ryan AbilityLab.
- Completed
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT01632709 is a Phase 4 study that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 16 participants.
The verdict
NCT01632709, a Phase 4 study, has completed, sponsored by Shirley Ryan AbilityLab.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to see how Post Amputation Pain (PAP) affects the body and brain by using sensory testing (such as pinprick testing), taking pictures of your brain (using a functional magnetic resonance imaging (fMRI) machine) and biomedical interventions (such as an injection of pain medicine). All medicines and the fMRI machine used during this study are FDA approved. The investigators hope that by learning the causes of PAP, the investigators can help future amputees.
Interventions
- DRUG Placebo
- DRUG Bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2012-05 |
| Est. Completion | 2014-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01632709
The ClinicalTrials.gov registry entry for NCT01632709 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01632709 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01632709 about?
NCT01632709 is a clinical study titled "Pathophysiology of Post Amputation Pain". The purpose of this study is to see how Post Amputation Pain (PAP) affects the body and brain by using sensory testing (such as pinprick testing), taking pictures of your brain (using a functional magnetic resonance imaging (fMRI) machine) and biomedical interventions (such as an injection of pain m...
What is the current status of trial NCT01632709?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2012-05. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01632709?
The interventions under investigation include: Placebo (DRUG), Bupivacaine (DRUG).
Who is sponsoring clinical trial NCT01632709?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.